What causes elevated calcium levels and what additional tests are needed to evaluate hypercalcemia in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated Calcium and Required Diagnostic Tests

Primary hyperparathyroidism and malignancy account for approximately 90% of all hypercalcemia cases, making intact parathyroid hormone (PTH) the single most critical initial test to guide your diagnostic workup. 1

Major Causes of Hypercalcemia

PTH-Dependent Causes (Elevated or Inappropriately Normal PTH)

  • Primary hyperparathyroidism is characterized by elevated or inappropriately normal PTH levels in the presence of hypercalcemia, typically caused by parathyroid adenoma or hyperplasia 2, 1
  • Primary hyperparathyroidism tends to present with lower calcium levels (<12 mg/dL), longer duration (>6 months), kidney stones, hyperchloremic metabolic acidosis, and no anemia 3

PTH-Independent Causes (Suppressed PTH <20 pg/mL)

  • Malignancy (solid tumors and hematological) represents 49.1% and 16.5% of hospitalized hypercalcemia cases respectively, with oral cavity carcinoma and multiple myeloma being most common 4
  • Malignancy-associated hypercalcemia presents with rapid onset, higher calcium levels (often >12 mg/dL), severe symptoms, marked anemia, but never kidney stones or metabolic acidosis 3, 5
  • Vitamin D toxicity (definite 8%, probable 3.5%) has emerged as an increasingly important iatrogenic cause over the past decade 4
  • Granulomatous diseases such as sarcoidosis cause hypercalcemia in approximately 6% of patients through increased 1α-hydroxylase production by granulomatous macrophages 2, 4
  • Medications including thiazide diuretics, lithium, calcium supplements, vitamin D supplements, vitamin A, calcitriol, and vitamin D analogues 1, 6
  • Chronic kidney disease accounts for 4.9% of cases 4

Essential Diagnostic Algorithm

First-Line Laboratory Tests (Order Immediately)

  • Serum intact PTH - this is your most important discriminating test 2, 7, 1
  • Total serum calcium and albumin to calculate corrected calcium using: Corrected calcium (mg/dL) = Total calcium + 0.8 × [4.0 - Serum albumin (g/dL)] 8, 7
  • Ionized calcium (normal 4.65-5.28 mg/dL) for definitive assessment, especially when albumin is abnormal 8, 7
  • Serum creatinine and BUN to assess renal function 7, 1
  • Serum phosphorus (typically low-normal in primary hyperparathyroidism) 8, 7
  • Serum magnesium 7

Second-Line Tests Based on PTH Results

If PTH is elevated or inappropriately normal (suggesting primary hyperparathyroidism):

  • 25-hydroxyvitamin D - must be measured because vitamin D deficiency causes secondary hyperparathyroidism and must be excluded before diagnosing primary hyperparathyroidism 2, 8
  • 1,25-dihydroxyvitamin D - measure together with 25-hydroxyvitamin D as their relationship provides critical diagnostic information 7
  • 24-hour urine calcium or spot urine calcium/creatinine ratio to assess for hypercalciuria and kidney stone risk 8, 7
  • Renal ultrasonography to evaluate for nephrocalcinosis or kidney stones 8
  • Bone density scan if chronic hyperparathyroidism is suspected 8

If PTH is suppressed (<20 pg/mL, indicating PTH-independent cause):

  • PTH-related protein (PTHrP) - elevated in humoral hypercalcemia of malignancy 8, 7, 5
  • 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D together - in sarcoidosis, 25-OH vitamin D is typically low (84% of patients) while 1,25-(OH)2 vitamin D is elevated (11% of patients) due to extrarenal 1α-hydroxylase activity 2, 7
  • Serum protein electrophoresis and immunofixation if multiple myeloma suspected 4
  • Chest imaging if lung cancer or sarcoidosis suspected 4

Critical Interpretation Nuances

PTH Assay Considerations

  • PTH measurements can vary up to 47% between different assay generations (second vs. third generation), so always use assay-specific reference values 2, 8
  • PTH is more stable in EDTA plasma than serum and at 4°C than room temperature - specify EDTA plasma collection 2, 8
  • Biological variation of PTH is substantial (20% in healthy individuals), so differences must exceed 54% to be clinically significant 8
  • PTH reference values are 20% lower in vitamin D-replete individuals compared to those with unknown vitamin D status 2, 8

Vitamin D Pattern Recognition

  • Primary hyperparathyroidism: Elevated PTH, elevated 1,25-(OH)2 vitamin D (PTH stimulates conversion), variable 25-OH vitamin D 2
  • Sarcoidosis/granulomatous disease: Suppressed PTH, low 25-OH vitamin D (84%), elevated 1,25-(OH)2 vitamin D (11%) 2, 7
  • Malignancy: Suppressed PTH, decreased 25-OH vitamin D (hypercalcemia suppresses PTH which normally drives conversion to active form) 8
  • Vitamin D toxicity: Suppressed PTH, elevated 25-OH vitamin D, variable 1,25-(OH)2 vitamin D 1

Race, Age, and BMI Adjustments

  • PTH concentrations are higher in Black individuals compared to White individuals 2
  • PTH increases with age due to declining GFR, resulting in higher PTH in patients over 60 years 2
  • PTH concentration is higher in obese patients (BMI-dependent) 2

Common Diagnostic Pitfalls to Avoid

  • Never rely on corrected calcium alone - always measure ionized calcium when albumin is abnormal to avoid pseudo-hypercalcemia from hemolysis or improper sampling 8, 9
  • Never order parathyroid imaging before confirming biochemical diagnosis - imaging (ultrasound, 99mTc-sestamibi SPECT/CT) is for surgical planning only, not diagnosis 8
  • Never diagnose primary hyperparathyroidism without excluding vitamin D deficiency first - vitamin D deficiency causes secondary hyperparathyroidism with elevated PTH 2, 8
  • Always measure BOTH 25-hydroxyvitamin D AND 1,25-dihydroxyvitamin D together - their relationship is diagnostically critical, especially for granulomatous diseases 9, 7
  • Check medication list thoroughly - thiazides, lithium, calcium supplements (>500 mg/day), vitamin D (>400 IU/day), vitamin A, calcitriol, and calcium-based phosphate binders are common culprits 9, 1, 6

Special Population Considerations

  • Chronic kidney disease patients: Distinguish secondary hyperparathyroidism (hypocalcemia or normal calcium with elevated PTH) from tertiary hyperparathyroidism (autonomous hypercalcemia with elevated PTH) 8, 7
  • Patients on dialysis: Consider dialysate calcium concentration effects on PTH and calcium balance 8, 7
  • Dehydration: Can concentrate blood components causing falsely elevated calcium - check serum osmolality (>300 mOsm/kg indicates dehydration) 7

References

Research

Hypercalcemia: A Review.

JAMA, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypercalcemia: an evidence-based approach to clinical cases.

Iranian journal of kidney diseases, 2009

Research

Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.

North American journal of medical sciences, 2015

Guideline

Diagnostic Approach for Hypercalcemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hypercalcemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Hypercalcemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Can I give syrup (syp) lactulose to a patient with hypercalcemia who is taking tramadol?
What are the causes of hypercalcemia (elevated calcium levels)?
How to manage a patient with hypercalcemia?
How should hypercalcemia be treated?
What is the management of malignant hypercalcemia in a patient?
What is the optimal treatment approach for a young to middle-aged adult patient with traumatic injuries in a Mobile Army Surgical Hospital (MASH) unit setting, considering potential multiple injuries and complications?
What is the approach to using dopamine and pressure support in a patient with an inferior myocardial infarction (MI) and potential hypotension?
What is the risk of hydroxychloroquine (Plaquenil) toxicity in patients with chronic conditions like rheumatoid arthritis or lupus who require therapy for over 20 years?
What is the management approach for a diabetic patient presenting with chest pain, ST depression in leads I and AVL, and ST elevation in lead III, suggesting a possible acute coronary syndrome?
What is the recommended treatment approach for an older patient with tri-vessel (three-vessel) disease, significant stenosis, and multiple comorbid conditions such as diabetes, hypertension, and previous myocardial infarction: percutaneous coronary intervention (PCI) with drug-eluting stents or coronary artery bypass grafting (CABG)?
What is the first line treatment for suspected Methicillin-resistant Staphylococcus aureus (MRSA) cellulitis in a patient with chronic kidney disease (CKD) and impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.